Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group.
about
13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadMature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).Pediatric lymphomas in Brazil.Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingOutcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapyUCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.Germinal-center type B-cell classification and clinical characteristics of Chinese pediatric diffuse large B-cell lymphoma: a report of 76 casesNodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.B-cell lymphomas involving Waldeyer's ring characterized by distinctive clinical and histopathological features: a comparison of pediatric to adult patientsMorphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients.Chronic myeloid leukemia as a secondary malignancy after lymphoma in a child. A case report and review of the literature.Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.Treatment of adolescents with aggressive B-cell malignancies: the pediatric experience.New targets for antibody therapy of pediatric B cell lymphomas.Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizons.Adolescent and young adult non-Hodgkin lymphoma.Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents.Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.An Atypical Presentation of Sporadic Jejunal Burkitt's Lymphoma.Molecular Subtypes, Apoptosis and Proliferation Status in Indonesian Diffuse Large B-Cell Lymphoma CasesNon-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective
P2860
Q21133027-83F166F4-5295-41CD-BFAE-CE363B76AD44Q26797513-2C844D78-9A66-4DAD-A0BD-DA5FDD64BEC5Q30240133-C6078054-246F-4986-82B6-A3D1FEAAD8D9Q33759495-EDB33577-486B-4F4C-9C5C-239F51D35369Q34486959-69B10E51-DD8F-444F-8EEA-84929AA4BF11Q35083003-1263B00B-C7C3-41A1-872E-49D1936A5C34Q35909668-C7FB7263-4E25-4F37-B647-868BA9AEF468Q36529482-BFD3EE45-0A5D-4CC6-A37C-DBC7C48DE86BQ36727872-9273E009-FE26-486F-A863-4CAADD4C44DAQ37353917-A26AADF5-682D-4A68-A7EE-B50123DE610DQ37457207-E0BDFEFB-9CA2-4369-B447-0B4FD04FD3B9Q37706947-DC95782F-6261-4764-8261-3323841ACA92Q37899197-0E581EAF-D037-465D-9094-A98C6FD72691Q38059423-CB4DD1B3-B07B-4D41-89BD-34E1183FBEC7Q38097544-CD4A6950-F24C-4C31-B9B8-B38610E69C86Q38118167-F57DDF13-BB4B-4E22-9B46-A67F4581025BQ38242984-440FBC87-C5DC-4D6C-982A-4643CE161079Q38771110-B4B8D8FA-9EDD-4053-AAA8-6B0E1DB0EEC3Q38790957-F427B1B7-AEB3-4E8B-BFFB-59404CB06464Q38806478-5E37E1A3-FC5E-4B6D-9896-98F6D8646049Q39393429-EAA61F9E-F8EB-4515-8E7A-8382F6495BD8Q40331337-AFAF7877-E947-44DD-9DAC-105304298C6EQ41146867-C684F2ED-04FC-43EC-8EED-53768EA569EAQ49648511-F36D2B70-FE37-46EA-842C-FFAE6B297BE8Q51535308-AD2DA1A8-A7E5-4FB3-8A00-16EADA5955FCQ57174502-109A42F6-91BB-4A53-B63E-EA2B6AB16DAB
P2860
Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pediatric diffuse large B-cell ...... AB) international study group.
@en
Pediatric diffuse large B-cell ...... AB) international study group.
@nl
type
label
Pediatric diffuse large B-cell ...... AB) international study group.
@en
Pediatric diffuse large B-cell ...... AB) international study group.
@nl
prefLabel
Pediatric diffuse large B-cell ...... AB) international study group.
@en
Pediatric diffuse large B-cell ...... AB) international study group.
@nl
P2093
P2860
P356
P1476
Pediatric diffuse large B-cell ...... AB) international study group.
@en
P2093
Anne Auperin
Catherine Patte
Keith McCarthy
Marie J Terrier-Lacombe
Mark A Lones
Martine Raphael
Mary Gerrard
Mitchell S Cairo
Richard Sposto
Rodney R Miles
P2860
P304
P356
10.1002/PBC.21619
P577
2008-09-01T00:00:00Z